Navigation Links
BSGI/MBI Enhances Pre-Surgical Planning For Patients With Newly Diagnosed Breast Cancer
Date:11/30/2011

NEWPORT NEWS, Va., Nov. 30, 2011 /PRNewswire/ -- According to a new study, Breast-Specific Gamma Imaging (BSGI), also known as Molecular Breast Imaging (MBI), can provide critical information in the initial diagnostic workup and surgical planning for patients with newly diagnosed breast cancer. Adding BSGI/MBI to conventional imaging (CI), namely mammography and ultrasound, enhances pre-surgical planning. These findings will be presented at the 2011 Radiological Society of North America (RSNA) annual meeting to be held in Chicago, Nov. 27 through Dec. 2, 2011.

In a retrospective review of records at Scripps Clinic (San Diego, Calif.), BSGI/MBI confirmed, clarified or added to findings of conventional imaging in 75 percent of patients. BSGI/MBI identified an additional lesion or significantly changed management in 20 percent of cases. BSGI was unhelpful or led to an additional nine biopsies or work-up in 25 percent of patients. The study concludes that BSGI/MBI was found to be cost-effective, well-tolerated, and was a reasonably sensitive and specific adjunct modality for enhancing pre-surgical planning for patients with newly diagnosed breast cancer, especially in relatively young female patients with dense breast tissue. For this study BSGI/MBI was conducted with a high-resolution gamma camera, the Dilon 6800®.

"Based on our review of our first year's experience with breast cancer patients who had BSGI prior to undergoing cancer treatment surgery, we have a better understanding of the modality's strengths and limitations," said Marie Tartar, M.D., of Scripps Health.

"Like all breast imaging modalities, BSGI will not identify all cancers. However, we have found in selected patients needing further evaluation for persistent questions after conventional breast imaging work-up (mammogram and/or ultrasound), BSGI can be useful and may be the first modality to indicate the presence of a breast cancer. Based on our results, BSGI seems to be an acceptable alternative to pre-operative local staging of breast cancer, if additional imaging beyond mammography and ultrasound is indicated, and a patient cannot or prefers not to undergo MRI," said Tartar.

About BSGI/MBIAs a follow-up to mammography, BSGI/MBI utilizes the Dilon 6800® Gamma Camera to help physicians more clearly differentiate benign from malignant tissue. To perform BSGI/MBI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal healthy cells and generally appear as dark spots on the BSGI/MBI image.

About Dilon DiagnosticsDilon Diagnostics, a brand of Dilon Technologies Inc., is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI/MBI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI/MBI to their patients, such as Cornell University Medical Center, New York, and The George Washington University Medical Center, Washington, D.C. For more information on Dilon Technologies please visit www.dilon.com.Media contact: Kristine BrownP: 847-528-2145E: kbrown@imschicago.com
'/>"/>

SOURCE Dilon Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Shows BSGI/MBI Contributes Significantly to Patient Management with Its Ability to Detect Breast Cancer in Difficult to Diagnose Patients
2. BSGI/MBI Shows Greater Sensitivity and Comparable Specificity When Compared to Ultrasound and Mammography
3. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
4. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
5. Des Moines Register Reports SpectraScience LUMA Enhances Cervical Cancer Exams
6. Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
7. ClinOps, LLC Enhances Senior Management Team With Addition of Connie Andrews as Senior Vice President of Clinical Operations
8. Infinitus Clinical Research Consolidates- Sino-Indian CRO Enhances Core Capabilities
9. PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument
10. Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings
11. Infinitus Clinical Research Consolidates - Sino-Indian CRO Enhances Core Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016 Dignitana, a world leader ... with Boa® Technology, creator of the award-winning, patented Boa® ... use with the DigniCap® scalp cooling system. DigniCap® was ... December 2015, and is the first medical scalp cooling ... scalp cooling system features a patented tight-fitting silicone cooling ...
(Date:12/8/2016)... in the United States will continue in 2017, say ... December 2016 Semiannual Economic Forecast. Expectations are for a ... as indicated in the monthly ISM ® ... is optimistic about growth in 2017, with revenues expected ... sector indicates that 14 of its industries will see ...
(Date:12/8/2016)... 8, 2016 According to a new market research ... Fetal), Therapeutic (Pain, Insulin)), End Use (Sports, Fitness, RPM), Type (Smart watch, ... the global market, in terms of value, is projected to reach 12.14 ... of 18.0% during the forecast period. Continue ... ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... 08, 2016 , ... ZyDoc , a New York-based ... Data Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” ... comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s leading digital and ... with Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group ... said, “CURE Media Group is honored to team up with Upstage Lung Cancer in ...
(Date:12/8/2016)... ... 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing ... wellness program, at their world headquarters of Omni La Costa Resort & Spa in ... anyone seeking weight loss, personal development, a healthy lifestyle, or mental and physical healing. ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
(Date:12/8/2016)... ... ... California Senate Bill (SB) 863, signed into law in 2012, may have ... according to CompScope™ Medical Benchmarks for California, 17th Edition , a study by ... payments per claim in California decreased 4 percent in 2013 and then 3 percent ...
Breaking Medicine News(10 mins):